Literature DB >> 21921677

The growing role of nanotechnology in combating infectious disease.

Karin Blecher1, Adnan Nasir, Adam Friedman.   

Abstract

The treatment and prevention of infectious diseases is a major part of both clinical and investigative medicine. As the use of conventional antibiotics rises, antimicrobial resistance patterns develop, necessitating the continuous need for newer and more effective therapies. Nanotechnology, defined as the production and application of materials in the nanoscale range (1-100 nm), has been the focus of several investigations as a result of unique physical and chemical properties of nanomaterials. . Specifically, nanomaterials provide added benefits due to their small size; allowing for an increased ability to surpass most physiologic barriers and reach their intended targets, and high surface area-to-volume ratio, allowing for increased potential to interact with pathogen membranes and cell walls. This review focuses of the potential therapeutic and preventative applications of nanotechnology-based drug delivery systems in infectious disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921677     DOI: 10.4161/viru.2.5.17035

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  40 in total

Review 1.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

2.  Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.

Authors:  Xi Zhu; Aleksandar F Radovic-Moreno; Jun Wu; Robert Langer; Jinjun Shi
Journal:  Nano Today       Date:  2014-08-01       Impact factor: 20.722

3.  Green synthesis of gold nanoparticles using extracellular metabolites of fish gut microbes and their antimicrobial properties.

Authors:  T Rajasekar; K Karthika; G Muralitharan; A Maryshamya; S Sabarika; S Anbarasu; K Revathy; N Prasannabalaji; S Kumaran
Journal:  Braz J Microbiol       Date:  2020-05-18       Impact factor: 2.476

Review 4.  Antimicrobial hydrogels: promising materials for medical application.

Authors:  Kerong Yang; Qing Han; Bingpeng Chen; Yuhao Zheng; Kesong Zhang; Qiang Li; Jincheng Wang
Journal:  Int J Nanomedicine       Date:  2018-04-12

Review 5.  Synergism between metallic nanoparticles and antibiotics.

Authors:  Maria Anndressa Alves Agreles; Iago Dillion Lima Cavalcanti; Isabella Macário Ferro Cavalcanti
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-07       Impact factor: 4.813

Review 6.  Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies.

Authors:  Lanying Du; Yang Yang; Xiujuan Zhang; Fang Li
Journal:  Nanoscale       Date:  2022-01-27       Impact factor: 7.790

7.  Synthesis, characterization and antimicrobial activity of conjugates based on fluoroquinolon-type antibiotics and gelatin.

Authors:  Giuseppe Cirillo; Maria Vittoria Mauro; Umile Gianfranco Spizzirri; Paolina Cavalcanti; Francesco Puoci; Cristina Giraldi; Orazio Vittorio; Nevio Picci; Francesca Iemma
Journal:  J Mater Sci Mater Med       Date:  2013-10-09       Impact factor: 3.896

Review 8.  Nanomedicine for anticancer and antimicrobial treatment: an overview.

Authors:  Shatavari Kulshrestha; Asad U Khan
Journal:  IET Nanobiotechnol       Date:  2018-12       Impact factor: 1.847

9.  Development of piperazine-1-carbothioamide chitosan silver nanoparticles (P1C-Tit*CAgNPs) as a promising anti-inflammatory candidate: a molecular docking validation.

Authors:  C S Karthik; H M Manukumar; S Sandeep; B L Sudarshan; S Nagashree; L Mallesha; K P Rakesh; K R Sanjay; P Mallu; Hua-Li Qin
Journal:  Medchemcomm       Date:  2018-04-04       Impact factor: 3.597

10.  Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.

Authors:  Adam J Friedman; Jenny Phan; David O Schairer; Jackson Champer; Min Qin; Aslan Pirouz; Karin Blecher-Paz; Ami Oren; Phil T Liu; Robert L Modlin; Jenny Kim
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.